In a next step, we evaluated xenograft experiments with WNT2 overexpressing HCT116 colon cancer cells that we recently published on the role of WNT2 as a driver in colorectal cancer progression [24] to investigate the in vivo relevance of our findings. The gene discussed is WNT2; the disease is colorectal cancer.